The ABI2 Knockout SK-HEP-1 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population that provides a loss-of-function system for studying the adaptor protein ABI2 in a hepatocellular carcinoma background. This product introduces target-gene disruption in SK-HEP-1 cells, generating a heterogeneous pool of edited alleles without single-cell cloning. The polyclonal nature preserves cellular heterogeneity while diminishing functional ABI2 expression, enabling robust assessment of ABI2-dependent phenotypes across a genetically diverse cell pool. This approach facilitates experiments requiring a broader representation of gene-edited outcomes, making it suitable for bulk assays where population-level effects are critical.
The host cell line SK-HEP-1 is an epithelial hepatocellular carcinoma line originally derived from the ascitic fluid of a patient with liver adenocarcinoma. This widely utilized model recapitulates key features of hepatocarcinogenesis and metastatic progression, including deregulated proliferation, cytoskeletal remodeling, and invasive behavior. SK-HEP-1 cells are extensively characterized for studying molecular mechanisms underlying liver cancer metastasis, making them a relevant platform for dissecting the contribution of ABI2 to tumor cell migration, adhesion, and cytoskeletal dynamics.
ABI2 functions as a core adaptor protein within the WAVE regulatory complex, directly linking upstream activation by Rac1 GTPase, c-Abl kinase, and growth factor receptors such as EGFR and PDGFR to actin nucleation via the Arp2/3 complex. In response to these signals, ABI2 assembles with CYFIP1, NCKAP1, HSPC300, and WAVE2 to form the active WAVE complex, which then stimulates Arp2/3 to promote branched F-actin polymerization. This cascade drives lamellipodia formation, membrane ruffling, and endocytic vesicle trafficking. ABI2 also interacts with c-Abl, Arg, and Cbl, integrating phosphorylation-dependent signaling events that fine-tune cytoskeletal reorganization. Knockout of ABI2 disrupts these protein?Cprotein interactions and compromises Rac1-to-Arp2/3 pathway transduction.
In the context of SK-HEP-1 cells, ABI2 loss impairs actin-based motility and endocytosis, two processes closely associated with hepatocellular carcinoma invasion and metastasis. By attenuating lamellipodia extension and cell migration, the knockout model provides a practical tool for investigating how ABI2-dependent actin remodeling contributes to the aggressive phenotype of liver cancer cells. This system enables researchers to dissect the molecular determinants of metastatic competence and evaluate whether targeting ABI2-dependent pathways could reduce tumor dissemination, offering insights relevant to anti-metastatic therapeutic strategies.
This knockout cell population is suited for functional studies, including wound healing and Transwell migration/invasion assays to quantify motility defects, phalloidin-based actin staining for cytoskeletal visualization, and Western blotting or co-immunoprecipitation to assess WAVE complex integrity. Live-cell imaging can capture membrane ruffling dynamics, while endocytosis assays (transferrin uptake) probe ABI2??s role in vesicle internalization. Additional applications include RT-qPCR, cell adhesion experiments, and drug screening for anti-metastatic compounds. For further details and technical support, researchers are encouraged to contact Ascent Research.
